Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

The patient improved with treatment for depilating folliculitis.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Mitochondrial stress can lead to atopic dermatitis.

The role of γδT-cells in causing alopecia areata remains unclear.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

High retinol intake may worsen hair loss in alopecia areata.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Isotretinoin treatment improved scalp condition and stopped hair loss.

Oral isotretinoin effectively treated the man's painful scalp condition and hair loss.

Actinic prurigo cheilitis can occur in elderly Asians and can be treated with hydrocortisone cream and sun protection.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Understanding skin microbes and sebum can help manage atopic dermatitis and hair loss.

An 18-year-old man was diagnosed with a rare genetic disorder causing hair loss, severe light sensitivity, and skin issues.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

The man's diarrhea was caused by a rare disorder called Cronkhite-Canada syndrome, which improved with specific medications.